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  Total joint arthroplasty (TJA) is one of the most common 
orthopaedic procedures. Nevertheless, several complica-
tions can lead to implant failure.
  Peri-prosthetic joint infections (PJI) certainly represent a 
significant challenge in TJA, constituting a major cause 
of prosthetic revision. The surgeon may have an impor-
tant role in reducing the PJI rate by limiting the impact of 
significant risk factors associated to either the patient, the 
operative environment or the post-operative care.
  In the pre-operative period, several preventive measures 
may be adopted to manage reversible medical comorbidi-
ties. Other recognised pre-operative risk factors are urinary 
tract infections, intra-articular corticosteroid injections and 
nasal colonisation with Staphylococcus (S.) aureus, particu-
larly the methicillin-resistant strain (MRSA).
  In the intra-operative setting, protective measures for 
PJI include antibiotic prophylaxis, surgical-site antisep-
sis and use of pre-admission chlorhexidine washing and 
pulsed lavage during surgery. In this setting, the use of 
plastic adhesive drapes and sterile stockinette, as well as 
using personal protection systems, do not clearly reduce 
the risk of infection. On the contrary, using sterile theatre 
light handles and splash basins as well as an increased 
traffic in the operating room are all associated with an 
increased risk for PJI.
  In the post-operative period, other infections causing 
transient bacteraemia, blood transfusion and poor wound 
care are considered as risk factors for PJI.
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Introduction
The number of total joint arthroplasties (TJAs) performed 
has increased steadily in recent years, with projected 
numbers for the coming years rising further.1 Conse-
quently, increasing incidence of TJA revision can also be 
expected.2 Differing causations hase been reported for TJA 
failure and revision.3,4 According to recent data, peri- 
prosthetic joint infection (PJI) incidence constitutes 
between approximately 0.3% and 1.7% of all total hip 
arthroplasties (THA), and between 0.8% and 1.9% of all 
total knee arthroplasties (TKA).4,5
PJI can be classified in intra-operative, early post-opera-
tive, acute haematogenous and chronic infections, accord-
ing to both timing and cause of infection.6
The risk factors potentially correlated with acute PJI 
infection can be divided into pre-operative (usually related 
to patient comorbidities), peri-operative and post- 
operative, which are mainly linked to the behaviours of 
the surgeon and the hospital staff.7 Conversely, chronic 
infections are less influenced by the conduct of the sur-
geon, as they are most often related to haematogenous 
diffusion of bacteria.6
The aim of this paper is to review the recent literature, 
summarising the most relevant risk factors that the sur-
geon can modify in order to reduce the incidence of peri-
prosthetic joint infection.
Pre-operative factors
Several studies demonstrated that some comorbidity can 
be associated with an increased risk of PJI.6,8-10 The Ameri-
can Academy of Orthopaedic Surgeons (AAOS) reported 
on the different risk factors for PJI and developed a guide-
line for PJI prevention and treatment.11
In 2013 an international group of orthopaedic sur-
geons gathered in Philadelphia, Pennsylvania to develop a 
‘consensus’ for definition, prevention and management 
of PJI, as an update to the previous guidelines. The con-
sensus included a list of potential risk factors associated 
with PJI. (Table 1).7
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Although the majority of these conditions must be con-
sidered as non-modifiable factors, many preventive meas-
ures may be adopted to reduce their impact on the 
development of PJI. Table 2 summarises the modifiable 
and non-modifiable factors related to PJI, including some 
preventive measures to manage reversible medical comor-
bidities, according to the existing literature.8-10,12-18
Other potential pre-operative risk factors are intra-artic-
ular corticosteroid injections and any infectious disease, 
particularly urinary tract infection (UTI) and nasal coloni-
sation with Staphylococcus (S.) aureus.19-25
The relationship between steroid injections and post-
operative PJI was evaluated in several studies. Papavasiliou 
et al19 reported an incidence of only 2% of infections in a 
series of 114 TKAs, but all of the infected TKAs had previ-
ously been treated with an intra-articular corticosteroid 
injection within the 11-month period prior to surgery.
Conversely, Desai et  al20 stated that the incidence of 
infection did not increase in patients with prior steroid 
injection treatment.
The correlation between post-operative UTIs and PJI 
has been demonstrated. However, the association 
between pre-operative bacteriuria and early deep infec-
tions remains uncertain.21,22
David and Vrahas23 defined an algorithm for urological 
evaluation before TJA. The presence of symptoms of a UTI 
in association with urinary leukocyte counts greater than 
1 × 104/mL and a bacterial count greater than 1 × 103/mL 
should be the only indication for surgical delay. Con-
versely, in asymptomatic patients it is still possible to pro-
ceed with TJA by treating those patients with urine colony 
counts greater than 1 × 103/mL.23
There may be a correlation between nasal colonisation 
with S. aureus and PJI. Different authors confirmed that 
being a high-level nasal carrier of S. aureus is an important 
and significant independent risk factor for developing SSI 
with S. aureus.24-26 Nasal application of mupirocin is 
widely accepted as treatment for nasal carriers of S. aureus. 
In a recent randomised controlled trial (RCT), mupirocin 
treatment resulted in a simple, safe and cost-effective 
intervention that can reduce the risk of SSI.27 However, 
literature still exists doubting the effectiveness of this treat-
ment in prevention.28-31
Intra-operative factors
Different intra-operative components may play an impor-
tant role as risk factors for developing PJI (Table 3).The first 
six hours following surgery are the most important regard-
ing infection, as during those hours the numbers of bacte-
ria multiply exponentially. Maintaining a low blood level 
Table 1. Potential risk factors for development of surgical site infection or 
peri-prosthetic joint infection after elective total joint arthroplasty, accord-
ing to The International Consensus on Periprosthetic Joint Infection7
Comorbidities
Poorly controlled diabetes mellitus (glucose > 200 mg/L or HbA1C >7%)
Poor nutritional state
Morbid obesity (BMI >40 Kg/m2)
Prolonged hospital admission
Severe immunodeficiency
Inflammatory arthropathy (rheumatoid arthritis)
Anaemia
Male sex
Excessive smoking (> one pack per day)
Excessive alcohol consumption (> 40 units per week)
Intravenous drug abuse
Active liver disease
Chronic renal disease
Diagnosis of post-traumatic arthritis
Prior surgical procedure in the affected joint
BMI, body mass index; HbA1c, glycated haemoglobin.
Table 2. Pre-operative modifiable and non-modifiable risk factors; measures the surgeon can adopt to reduce impact of risk factors on development of PJI
Non-modifiable risk factor Conditions favouring PJI Role of the surgeon
Obesity13,14 BMI > 40 Kg/m2 Weight loss
Antibiotic adaptation
Anemia15 Blood transfusion Iron supplementation; erythropoietin therapy
Nutritional status10 Serum albumin level < 34g/l
Low total lymphocyte levels
Correction of abnormal laboratory parameters
Diabetes16,17 HbA1c level > 8
Fasting blood glucose level of 200 mg/dL
Accurate peri-operative monitoring of blood glucose
Smoking11,18 >1 pack/day or 25 cigarettes Cessation between four and six weeks before surgery
Oral corticosteroid therapy12 Steroid doses over 15 mg/day Reduction or suspension
Rheumatoid arthritis19 Steroid doses over 15 mg/day
Other immunosoppressive agents 
(cyclophosphamide, methotrexate)
Reduction or suspension of immunosoppressive therapy with 
reumatologist collaboration
Modifiable risk factor Correlation with PJI incidence Role of the surgeon
Urinary tract infection23-25 Unclear Delay surgery when urine leukocytes count > 1 × 10(4)/mL and 
bacterial count > 1 × 10(3)/mL
Intra-articular corticosteroid injections20,21 Unclear Surgical delay of between six and 12 months
Nasal colonisation with S. aureus26-28 Influencing, predisposing Nasal MRSA bonification with mupirocin application (debated efficacy)
PJI, peri-prosthetic joint infections; BMI, body mass index; HbA1c, glycated haemoglobin; MRSA, methicillin-resistant staphylococcus aureus; S. aureus, staphylococ-
cus aureus
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of bacteria in this period is critical, and for this reason pro-
phylactic antibiotics are infused to decrease bacterial mul-
tiplication and to extend this ‘golden’ period.8 The 
pre-operative dose of antibiotics should be administered 
within one hour before the surgical incision; this can be 
extended to two hours for vancomycin and fluoroquinolo-
nes. Most authors agree that a single pre-operative pro-
phylactic infusion of cefazolin (1 gr if < 80 Kg; 2 gr if > 80 
Kg) is a good choice.7,8 However, recent studies have dem-
onstrated that targeted use of vancomycin and cefazolin 
among patients undergoing revision TKA significantly 
reduced the rate of overall infections, in particular of 
MRSA.32 Surgeons should consider additional antibiotic 
administration if the surgery time is twice the length of the 
half-life of the antibiotic, or whenever the blood loss 
exceeds 2000 mL and fluid resuscitation is over 2000 mL.7 
To reduce PJI infection rate, some authors advocate using 
antibiotic-loaded bone cement (ALBC) for the cementa-
tion. However, it was demonstrated that routine use of 
ALBC does not change the PJI rate, though it may be useful 
in the reduction of the PJI rate in high-risk patients (for 
example those with diabetes or immunosuppression).33,34
Surgical site preparation also plays a role in reducing 
PJI rate. Some authors have confirmed the reduction of PJI 
in patients who underwent pre-admission surgical site 
preparation using chlorhexidine washing.35 Different 
studies have evaluated the best solutions for surgical site 
preparation to reduce PJI. In a RCT conducted by Darouiche 
et  al, it was demonstrated that a chlorhexidine–alcohol 
solution was more protective than povidone–iodine 
against both superficial and deep infections. This is prob-
ably due to the more rapid action, persistent activity 
despite exposure to bodily fluids, and residual effect of 
chlorexidine compared with povidone.36
The preparation of the surgical site often includes using 
plastic adhesive drapes and sterile stockinette. However, a 
recent Cochrane review showed no evidence that adhe-
sive drapes reduce surgical site infection rates.37
The bactericidal action of incision drapes containing 
iodine is inferior to conventional skin preparation solu-
tions, so using incision drapes as a substitute for conven-
tional skin preparation is not recommended.7 Furthermore, 
Boekel et al38 concluded that the surgical field for TKA can 
be contaminated by proximal microbial spread from the 
unprepared foot with the use of a sterile stockinette drape. 
So the preparation of the foot is mandatory if combined 
with stockinette drapes.38
The risk of PJI is also directly correlated with the length 
of the surgery, which should be less than 2.5 hours as a 
reasonable cut-off point.8,39,40 Zhu et  al, in their meta-
analysis, concluded that increased operative time is asso-
ciated with a higher risk of PJI development (OR = 2.18, CI 
95% 1.39-3.42, p = 0.003). However, these data may also 
be correlated with the high complexity of long proce-
dures.10 Furthermore, the surgeon’s surgical volume may 
be directly associated with PJI: surgeons with low volumes 
may have higher rates of infection.41
Hand care is another crucial point in reducing PJI infec-
tion; hand surgical scrub recommendations were previ-
ously published by the Centers for Disease Control and 
Prevention.42 In particular, surgeons should remove debris 
from underneath the fingernails using a nail cleaner under 
running water, and either an antimicrobial soap or an 
alcohol-based hand rub should be used persistently for at 
least five minutes. Different studies evaluated the number 
of glove changes necessary to reduce the risk of PJI. Of 
note, Beldame et al43 recommended :
 • renewing outer gloves after draping (before placing a 
cutaneous adhesive);
 • opening the instrumentation secondarily, with a new 
glove change after handling instruments which may 
cause perforations;
 • renewing outer gloves after each surgical stage.
No strong evidence is available in the literature regarding 
the appropriate number of glove changes. Different 
authors recommended double gloving to reduce the risk 
of inner glove perforation, but no correlation with PJI has 
been demonstrated.44,45
The role of the personal protection system (PPS) in pre-
venting PJI is still debated. Kearns et al demonstrated that 
the external surface of the PPS cannot be assumed to be 
sterile after removal from the original packaging, and they 
suggested the need to change gloves if the PPS is touched 
or adjusted during the procedure.46 Other authors agree 
Table 3. Intra-operative factors potentially associated with PJIs
Correlated to reduced PJI risk Correlated to increased PJI risk Unclear factors Potential sources of infection
Intra-operative factors 
(surgeon’s role)
Antibiotic prophylaxis Portable devices Surgical gloves Sterile stockinette (no foot 
preparation)
Pre-admission chlorhexidine cloths Splash basins Laminar flow Personal protection system
Surgical site antisepsis Traffic in operating room Antibiotic-loaded bone cement Light handle
Ultraviolet light Use of plastic adhesive drapes  
 Pulsed lavage  
 Reduced operative time (< 2.5 hours)  
PJI, peri-prosthetic joint infections
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with the consideration of PPS as more a personal ‘protec-
tion’ than equipment specifically to reduce PJI.7,8,39
The operating room environment is another crucial 
point in preventing infection. Light handles can be a 
source of contamination, and surgeons must minimise 
their handling as far as possible. Furthermore a limited 
number of portable devices such as mobile telephones 
and tablet computers in the operating room is recom-
mended, although no evidence in the literature is able to 
link their use to increased risk.7
As airborne pathogens are a potential source of infec-
tion, the location and length of time that surgical instru-
ments remain exposed is related to contamination risk. 
For this reason, all instruments should be opened in oper-
ating rooms with clean air systems.7 Furthermore, during 
TJA, bloody instruments are commonly washed in ‘splash’ 
basins. These basins are repeatedly used during a surgical 
procedure and should therefore be considered a potential 
source of contamination.47 Anto et al demonstrated that 
23.8% of specimens from splash basins tested positive for 
bacterial contamination, and they suggested that sur-
geons should stop using them.48
The use of laminar flow to reduce PJI rate is another 
controversial topic. A recent systematic review showed no 
conclusive results regarding the utility of laminar flow in 
reducing PJI rate.49 Other authors agree that, despite the 
number of previous studies demonstrating the efficacy of 
laminar flow, more recent research has failed to prove this 
efficacy.7,8,39 Ultraviolet light seems to be more effective 
when compared with laminar flow in reducing PJI; how-
ever it is characterised by potentially unacceptable health 
costs to operative personnel.8,50,51
Traffic in the operating room is also a potential risk fac-
tor for PJI development. A level III study showed that the 
number of door openings had a role in increased infection 
rate.52
Surgeons may also play a role in reducing the rate of PJI 
using power-pulsed lavage or wound lavage at surgery. In 
a level IV study, power-pulsed lavage showed a statistically 
significant decrease in bacterial contamination.53
Post-operative factors
Different post-operative variables may also play a role as 
risk factors for PJI development.
Antibiotic prophylaxis for other surgical procedures 
before and after TJA, such as dental care or urological pro-
cedures, seems to play a role as a ‘protecting’ factor 
towards PJI by reducing the transient bacteraemia.54 
Despite the lack of literature demonstrating the relationship 
between dental procedures and PJI, the current recommen-
dation of the AAOS is to use antibiotic prophylaxis in 
patients with a TJA who are undergoing dental procedures, 
as well as any other invasive procedure.8,11,55 Furthermore, 
patients should be aware that any infection is a potential 
source of haematogenous dissemination. As previously 
reported by different authors, patients with TJA who have 
an active infection anywhere in the body are at risk of devel-
oping a PJI. For this reason, a prompt diagnosis and man-
agement of those infections is a mandatory prevention 
mechanism.8,56
There is still debate regarding the association between 
blood transfusion and PJI. In a level II study, Pulido et al57 
demonstrated that transfusion with allogenic blood is an 
independent risk factor for PJI. Patients receiving allogenic 
transfusions were 2.1 times more likely to develop PJI com-
pared with patients receiving no transfusion. In their study, 
Innerhofer et al concluded that allogenic filtered transfu-
sion is an independent variable for PJI prediction (OR 
23.65; CI 95%, 1.3-422.1; p = 0.01).58 Furthermore, the 
Centers for Disease Control and Prevention guidelines 
defined peri-operative allogeneic transfusion as a potential 
risk factor for developing PJI, but concluded that the inter-
pretation of the existing literature is difficult due to varia-
tions in assessment criteria.59 However, different measures 
can be adopted to reduce the need for blood transfusion, 
such as pre-operative screening for anaemia and its treat-
ment, intra-operative accurate haemostasis, minimisation 
of surgical time and use of tranexamic acid.8,59
Haematoma and persistent wound drainage were also 
related to an increased PJI rate; these conditions should be 
treated promptly with antibiotic prophylaxis, a decrease 
in anticoagulation dose, surgical evacuation of the hae-
matoma, irrigation and debridement and modular com-
ponent exchange.7,8
Wound care plays an important role in PJI prevention. 
Recently, more advanced surgical bandages such as 
hydrofibre absorbent dressings were proposed, with the 
aim of reducing the medication to allow for better wound 
healing and to prevent bacteria from entering the wound 
site from the external environment. In a level II study, Cai 
et al concluded that advanced surgical dressings such as 
hydrofibre may contribute to a reduction in the incidence 
of acute PJI.60
Conclusions
Infection represents a major challenge in TJA, and is costly 
and demanding to manage for both surgeons and 
patients. The main risk factors involved in PJI development 
are divided into pre-operative, intra-operative and post-
operative factors. Pre-operative risk factors are often 
related to patients’ comorbidities. The surgeon can act to 
reduce the impact of some reversible comorbidities, for 
example controlling glycaemia in diabetic patients or 
improving malnutrition. Various intra-operative risk fac-
tors such as operating theatre traffic, use of light handles, 
pulsed lavage or number of glove changes may also be 
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related to infection. Post-operative risk factors include 
transient bacteraemia related to dental procedures or 
other infections, wound care and blood transfusion as 
well as haematoma, and wound drainage should be con-
trolled with care.
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